How to incorporate new agents and immunotherapy into the stage III treatment paradigm?
R. Dziadziuszko
How to incorporate new agents and immunotherapy into the stage III treatment paradigm?
R. Dziadziuszko
LOCALLY-ADVANCED NSCLC: ADDRESSING THE CHALLENGES OF LARGE-VOLUME DISEASE